Prostaglandin E2-mediated regulation of immunoglobulin G2 via interferon gamma

Journal of Periodontology

Volumn 74, Issue 6, 2003, Pages 771-779

  Tanaka, Shigehisa ^a   Barbour, Suzanne E ^a   Best, Al M ^a   Schenkein, Harvey A ^a   Tew, John G ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

IgG; Immune response; Indomethacin; Interferon gamma; Periodontitis, aggressive pathogenesis; Prostaglandin E2

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INDOMETACIN; POKEWEED MITOGEN; PROSTAGLANDIN E2; RECOMBINANT INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 1ALPHA; RECOMBINANT INTERLEUKIN 6; IMMUNOGLOBULIN G; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 6; PROSTAGLANDIN SYNTHASE INHIBITOR; RECOMBINANT PROTEIN;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ARTICLE; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNOGLOBULIN PRODUCTION; IN VITRO STUDY; IN VIVO STUDY; KINETICS; MONONUCLEAR CELL; NORMAL HUMAN; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; REGULATORY MECHANISM; TH1 CELL; TH2 CELL; VOLUNTEER; ADULT; ANALYSIS OF VARIANCE; DRUG EFFECT; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; TIME;

ADULT; ANALYSIS OF VARIANCE; CELLS, CULTURED; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; HUMANS; IMMUNOGLOBULIN G; INDOMETHACIN; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-12; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; POKEWEED MITOGENS; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 0038637101     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2003.74.6.771     Document Type: Article

References (38)

1. Lu H, Wang M, Gunsolley JC, Schenkein HA, Tew JG. Serum immunoglobulin G subclass concentrations in periodontally healthy and diseased individuals. Infect Immun 1994;62:1677-1682.
2. Califano JV, Schifferle RE, Gunsolley JC, Best AM, Schenkein HA, Tew JG. Antibody reactive with Porphyromonas gingivalis serotypes K1-6 in adult and generalized early-onset periodontitis. J Periodontol 1999;70: 730-735.
3. Lu H, Califano JV, Schenkein HA, Tew JG. Immunoglobulin class and subclass distribution of antibodies reactive with the immunodominant antigen of Actinobacillus actinomycetemcomitans serotype b. Infect Immun 1993;61:2400-2407.
4. Wilson ME, Schifferle RE. Evidence that the serotype b antigenic determinant of Actinobacillus actinomycetemcomitans Y4 resides in the polysaccharide moiety of lipopolysaccharide. Infect Immun 1991;59:1544-1551.
5. Wilson ME, Hamilton RG. Immunoglobulin G subclass response of localized juvenile periodontitis patients to Actinobacillus actinomycetemcomitans Y4 lipopolysaccharide. Infect Immun 1992;60:1806-1812.
6. Gunsolley JC, Burmeister JA, Tew JG, Best AM, Ranney RR. Relationship of serum antibody to attachment level patterns in young adults with juvenile periodontitis or generalized severe periodontitis. J Periodontol 1987;58:314-320.
7. Califano JV, Gunsolley JC, Nakashima K, Schenkein HA, Wilson ME, Tew JG. Influence of anti-Actinobacillus actinomycetemcomitans Y4 (serotype b) lipopolysaccharide on severity of generalized early-onset periodontitis. Infect Immun 1996;64:3908-3910.
8. Muraguchi A, Hirano T, Tang B, et al. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med 1988;167:332-344.
9. Bertolini JN, Benson EM. The role of human interleukin-6 in B-cell isotype regulation and differentiation. Cell Immunol 1990;125:197-209.
10. Kawano Y, Noma T, Yata J. Regulation of human IgG subclass production by cytokines. IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2. J Immunol 1994;153: 4948-4958.
11. Nakagawa T, Hirano T, Nakagawa N, Yoshizaki K, Kishimoto T. Effect of recombinant IL-2 and gamma-IFN on proliferation and differentiation of human B cells. J Immunol 1985;134:959-966.
12. Jelinek DF, Splawski JB, Lipsky PE. The roles of interleukin-2 and interferon-gamma in human B cell activation, growth and differentiation. Eur J Immunol 1986; 16:925-932.
13. Defrance T, Aubry JP, Vanbervliet B, Banchereau J. Human interferon gamma acts as a B cell growth factor in the anti-IgM antibody co-stimulatory assay but has no direct B cell differentiation activity. J Immunol 1986;137:3861-3867.
14. Snapper CM, Peschel C, Paul WE. IFN-gamma stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J Immunol 1988;140: 2121-2127.
15. Snapper CM, McIntyre TM, Mandler R, et al. Induction of IgG3 secretion by interferon gamma: A model for T cell-independent class switching in response to T cell-independent type 2 antigens. J Exp Med 1992;175:1367-1371.
16. 2 and IFN-gamma. J Immunol 1992;148:3943-3949.
17. Zhang JB, Quinn SM, Rausch M, Gunsolley JC, Schenkein HA, Tew JG. Hyper-immunoglobulin G2 production by B cells from patients with localized juvenile periodontitis and its regulation by monocytes. Infect Immun 1996;64:2004-2009.
18. 2, IL-1 beta, IL-6, and TNF alpha by adherent mononuclear cells from early-onset periodontitis patients. J Periodontol 1994;65:139-146.
19. Ishihara Y, Zhang JB, Quinn SM, et al. Regulation of immunoglobulin G2 production by prostaglandin E(2) and platelet-activating factor. Infect Immun 2000;68: 1563-1568.
20. 2 enhancement of interferon-gamma production by antigen-stimulated type 1 helper T cells. Cell Immunol 1999;194:21-27.
21. Ishihara Y, Zhang JB, Fakher M, et al. Non-redundant roles for interleukin-1 alpha and interleukin-1 beta in regulating human IgG2. J Periodontol 2001;72:1332-1339.
22. Umetsu DT, Ambrosino DM, Quinti I, Siber GR, Geha RS. Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency. N Engl J Med 1985;313:1247-1251.
23. Barbour SE , Ishihara Y, Fakher M, et al. Monocyte differentiation in localized juvenile periodontitis is skewed toward the dendritic cell phenotype. Infect Immun 2002;70:2780-2786.
24. Rissoan MC, Soumelis V, Kadowaki N, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999;283:1183-1186.
25. Peters PM, Svedersky LP, Shalaby MR, Palladino MA Jr. Interferon gamma: More than a MAF. Lymphokine Res 1985;4:265-273.
26. Ioan-Facsinay A, de Kimpe SJ, Hellwig SM, et al. FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity 2002;16:391-402.
27. Heiner DC. IgG subclass composition of intravenous immunoglobulin preparations: Clinical relevance. Rev Infect Dis 1986;8 (Suppl 4):S391-S395.
28. Jefferis R, Pound J, Lund J, Goodall M. Effector mechanisms activated by human IgG subclass antibodies: Clinical and molecular aspects. Review article. Ann Biol Clin (Paris) 1994;52:57-65.
29. Siber GR, Santosham M, Reid GR, et al. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children. N Engl J Med 1990;323:1387-1392.
30. Lewis RA. Interactions of eicosanoids and cytokines in immune regulation. Adv Prostaglandin Thromboxane Leukot Res 1990;20:170-178.
31. 2 and IL-4 provide naive CD4+ T cells with distinct inhibitory signals for the priming of IFN-gamma production. Cell Immunol 1997;181:86-92.
32. 2 primes naive T cells for the production of anti-inflammatory cytokines. Eur J Immunol 1997;27:3526-3531.
33. 2, promote Th2 responses. Adv Exp Med Biol 1997;417:363-367.
34. 2, promote type 2 cytokine production in maturing human naive T helper cells. J Immunol 1997;159:28-35.
35. 2 promotes B lymphocyte Ig isotype switching to IgE. J Immunol 1995;154:162-170.
36. Fedyk ER, Harris SG, Padilla J, Phipps RP. Prostaglandin receptors of the EP2 and EP4 subtypes regulate B lymphocyte activation and differentiation to IgE-secreting cells. Adv Exp Med Biol 1997;433:153-157.
37. 2 promotes IL-4-induced IgE and IgG1 synthesis. J Immunol 1990;145:2644-2651.
38. 2 and cAMP inhibit B lymphocyte activation and simultaneously promote IgE and IgG1 synthesis. J Immunol 1992;149:2984-2991.